- Osram strengthens portfolio for security applications via acquisition
- ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development.
- Group14 Technologies Q&A with Dr. John Chen
- ReForm Biologics Secures New Patent Expanding Coverage of Key Excipient Formulation for Antibody-Based Therapeutics
- AbSci hopes to make E. Coli great again through engineered expression system